Sculati Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Sculati Wealth Management, LLC

$233 Million
Q2 2024

A detailed history of Sculati Wealth Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sculati Wealth Management, LLC holds 2,009 shares of REGN stock, worth $1.52 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

2,009

Previous 2,047 1.86%

Holding current value

$1.52 Million

Previous $1.97 Million 7.16%

% of portfolio

0.91%

Previous 0.85%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$883.2 - $1071.19 $33,561 - $40,705	-38 Reduced 1.86%	2,009 $2.11 Million
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $13,540 - $14,900	15 Added 0.74%	2,047 $1.97 Million
Q3 2023 Nov 09, 2023	SELL	$692.45 - $844.37 $77,554 - $94,569	-112 Reduced 5.22%	2,032 $1.67 Million
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $29,401 - $34,874	-42 Reduced 1.92%	2,144 $1.54 Million
Q1 2023 May 05, 2023	SELL	$680.49 - $826.97 $8,846 - $10,750	-13 Reduced 0.59%	2,186 $1.8 Million
Q3 2022 Nov 15, 2022	SELL	$573.97 - $724.32 $5,739 - $7,243	-10 Reduced 0.45%	2,199 $1.52 Million
Q2 2022 Aug 09, 2022	SELL	$548.35 - $738.84 $54,286 - $73,145	-99 Reduced 4.29%	2,209 $1.31 Million
Q1 2022 May 10, 2022	BUY	$595.12 - $698.43 $65,463 - $76,827	110 Added 5.0%	2,308 $1.61 Million
Q4 2021 Feb 07, 2022	BUY	$543.48 - $670.97 $71,195 - $87,897	131 Added 6.34%	2,198 $1.39 Million
Q3 2021 Nov 02, 2021	BUY	$574.03 - $680.96 $60,273 - $71,500	105 Added 5.35%	2,067 $1.25 Million
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $65,246 - $77,078	138 Added 7.57%	1,962 $1.1 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $247,041 - $303,154	553 Added 43.51%	1,824 $863,000
Q4 2020 Feb 10, 2021	BUY	$478.3 - $607.98 $14,349 - $18,239	30 Added 2.42%	1,271 $614,000
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $167,783 - $202,728	308 Added 33.01%	1,241 $695,000
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $460,267 - $600,777	933 New	933 $582,000

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sculati Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sculati Wealth Management, LLC with notifications on news.

Account

Sculati Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History